Retinai’s Post

Another great step forward for Precision Medicine, as SurgeCare closes out a €7.5M funding round, with several new strategic investors joining the cause. Led by Eurazeo, the round also included involvement from new investors Kima Ventures, Teampact.ventures, and Malakoff Humanis. Alongside previous investors HCVC, 50 Partners, and Boutique Venture Partners. I caught up with Co-founder & CEO Julien who let me know that "𝗪𝗶𝘁𝗵 𝘁𝗵𝗶𝘀 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗿𝗼𝘂𝗻𝗱, 𝗦𝘂𝗿𝗴𝗲 𝗮𝗺𝗯𝗶𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗯𝗲𝗰𝗼𝗺𝗲 𝗮 𝗹𝗲𝗮𝗱𝗲𝗿 𝗶𝗻 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗶𝗺𝗺𝘂𝗻𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀. 𝗧𝗵𝗲 𝗰𝗼𝗺𝗶𝗻𝗴 𝗺𝗼𝗻𝘁𝗵𝘀 𝘄𝗶𝗹𝗹 𝗺𝗮𝗿𝗸 𝘁𝗵𝗲 𝗼𝗽𝗲𝗻𝗶𝗻𝗴 𝗼𝗳 𝗦𝘂𝗿𝗴𝗲𝗟𝗮𝗯™, 𝗼𝘂𝗿 𝗽𝗿𝗲𝗺𝗶𝗲𝗿 𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗱𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝘁𝗼 𝘁𝗵𝗲 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗼𝗳 𝗶𝗺𝗺𝘂𝗻𝗲 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗳𝗶𝗻𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗣𝗿𝗲𝗖𝘆𝘁𝗲®‘𝘀 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻, 𝗼𝘂𝗿 𝗳𝗹𝗮𝗴𝘀𝗵𝗶𝗽 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝘁𝗲𝘀𝘁 𝗳𝗼𝗿 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗶𝗻 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 𝘀𝗲𝘁𝘁𝗶𝗻𝗴𝘀" With the deployment of PreCyte® and SurgeLab™, Surge is taking steps revolutionize precision medicine. These cutting edge solutions, coupled with a team with combined expertise and shared values of scientific rigor, patient-centered approaches, value-based care, and translational medicine, Surge has positioned itself for huge things in the years to come. Congratulations to the entire Surge team and various investors involved in this round! One to to definitely keep an eye on. #precisionmedicine #venturecapital #digitalhealth #capitalgrowth

Ark Surgical Ltd., a pioneering medical device company within the www.intempo.ventures portfolio, has secured $1.1 million to advance safer surgical solutions tailored specifically for Women's Health. Sealed between December 2023 and January 2024, this investment marks a pivotal milestone for Ark Surgical as it pursues its mission to improve women's healthcare with safer surgical interventions. The infusion of funds will predominantly fuel the company's strategic expansion efforts in the United States, particularly in promoting its FDA-cleared tissue containment system, the #LapBox. Entities in this funding round include Intempo Ventures, #NGT3, the Israel Innovation Authority (IIA), and the Israel Ministry of Economy and Industry. Additionally, Ark Surgical has garnered support from a distinguished U.S.-based medical device group comprising seasoned physicians and executives renowned for their extensive expertise in the healthcare landscape. #LapBox containment system directly addresses the FDA's imperative to mitigate the risk of undiagnosed cancer dissemination during tissue morcellation, all while enhancing patient outcomes by facilitating minimally invasive alternatives to conventional, higher-risk open surgeries. Learn more in Femtech Insider > https://lnkd.in/dtnpAA7E #womenshealth #gynecology #medtech #healthcareinvestment #medicaldevices

More exciting news, as Myoptechs joins our portfolio!

👏 UroMems raised $47m in its largest fundraising round so far, to finance clinical trials of the UroActive smart automated implant for stress urinary incontinence in the US and Europe. 👉 The Series C funding round was led by Crédit Mutuel Innovation and saw participation from the European Innovation Council and SMEs Executive Agency (EISMEA), along with the existing investors Bpifrance, Wellington Partners, Supernova Invest, b-to-v Partners, HIL-INVENT Ges.m.b.H., and FINANCIERE ARBEVEL. 📣 UroMems CEO Hamid Lamraoui said: “The confidence of our new and existing investors combined with the strength of our compelling results and tremendous physician interest shows the high potential of our technology. 🔗 Read more: https://lnkd.in/dg4Nywtd #MedicalDevice #MedicalEquipment #HealthTech #MedicalDevices #Urinary #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect

We are thrilled to announce the first close of our USD 8M (CHF 6.73M) Series B funding led by Sanoptis, with continued support from existing investors including THINC Ventures (Topcon Healthcare Inc.), Zürcher Kantonalbank, and Verve Ventures. This funding will accelerate the development and commercialization of 𝐑𝐞𝐭𝐢𝐧𝐀𝐈 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲®️ and 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐂𝐎𝐍𝐍𝐄𝐂𝐓™️, enabling seamless data connectivity and AI-driven insights in ophthalmology, optometry and beyond. Through our partnership with Sanoptis, we are bringing cutting-edge AI solutions to hundreds of clinics across Europe, enhancing patient care and data workflows in the clinic. Our journey doesn’t stop here! Through Ikerian we are expanding our capabilities into new therapeutic areas, including neurodegenerative disorders and rare diseases, leveraging real-world evidence (RWE) and AI to support better decision-making in healthcare. A big thank you to our partners, investors, and the incredible Ikerian / Retinai team for making this milestone possible! Learn more 👉 https://lnkd.in/ei8x7-w6 💡 Stay tuned for more updates as we continue to revolutionize healthcare through data and AI💡 #SeriesB #HealthTech #AIinHealthcare #Ophthalmology #DataDriven #HealthcareInnovation #eyecare #machinelearning #artificialintelligence #innovation

EU-Startups reports on the latest funding round of Symphera, a promising Munich-based medtech company. Symphera raised €2.4 million in a seed round led by HTGF | High-Tech Gründerfonds with participation from Bayern Kapital and CARMA FUND Management GmbH. The company is developing advanced surgical systems for laparoscopic procedures, and with this funding, they plan to conduct pre-clinical tests and prepare for certification. Leading voices like Jan Engels from HTGF and Monika Steger from Bayern Kapital voiced strong support for Symphera's potential to improve surgical workflows and patient outcomes. https://lnkd.in/gUHTu6Wd #HealthTech

This is optimal.

GS Capital Connect customer AI Medical Technology has closed a Seed funding round ! AI Medical Technology announced the successful closure of an oversubscribed bridge financing round worth SEK12 (US$1m). Funding was provided by existing investors, such as Northern Venture Northern CapSek Ventures, and new shareholders. The money will be used to support ongoing regulatory efforts and development of the company’s AI-driven support tool, Dermalyser, a clinically validated decision support tool for the diagnosis of malignant melanomas. 💬 Christoffer Ekstrom, CEO, commented: "Our roadmap is now consolidated – we will raise more funds in a Series A round this year and plan for an IPO in 2027-2028.” 🔗 Read more: https://lnkd.in/eyaJRisd #MedicalDevices #MedicalDevice #MedicalEquipment #Medicine #TechNews #Funding #MedTechFunding #FundingRound #ClinicalStudy #AngelInvestment #GSCapitalConnect

🆕 𝐆𝐢𝐥𝐝𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐜𝐨-𝐥𝐞𝐚𝐝𝐬 𝐨𝐯𝐞𝐫𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞𝐝 €𝟓𝟒 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐁 𝐫𝐨𝐮𝐧𝐝 𝐨𝐟 𝐀𝐫𝐠𝐚́ 𝐌𝐞𝐝𝐭𝐞𝐜𝐡 Argá Medtech SA, a company developing a next-generation #cardiacablation system for treating cardiac #arrhythmias, including #atrialfibrillation (AF), announced it closed a €54M oversubscribed Series B raise co-led by Gilde Healthcare with existing investors, Advent Life Sciences and Earlybird Venture Capital, as well as an undisclosed strategic investor. The financing enables Argá Medtech to advance the development of its innovative Pulsed Field Ablation (PFA) system for treating AF through the execution of an IDE study in the US and a CE Mark study in the EU. Read more: https://lnkd.in/dHPSSB-B #digitalhealth #healthinnovation

👏 ShiraTronics, Inc. closed a $66 million Series B financing round to support its Migraine Therapy System - programmable, minimally invasive, implantable neuromodulation system to address the symptoms of migraines. New investor Norwest Venture Partners led the Series B. Additional new investors Seroba., OSF Ventures, the Global BioAccess Fund and an undisclosed strategic investor also participated. Existing investors U.S. Venture Partners, Amzak Health, Treo Ventures and Aperture Venture Partners joined in, too. 💬 ShiraTronics, Inc. CEO Rob Binney commented: “We are deeply grateful for the support of our distinguished new and existing investors, and are laser-focused on delivering this breakthrough therapy to those in need.” 🔗 Read more: https://lnkd.in/eCRrbdNG #MedicalDevice #MedTech #MedicalEquipment #HealthTech #SeriesA #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect